Shinya Takuma

Title: Shinya Takuma: Innovator in Glycosylated Immunoglobulin Production

Introduction

Shinya Takuma is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of glycosylated immunoglobulins. With a total of 5 patents to his name, Takuma's work has advanced the understanding and application of immunoglobulin production methods.

Latest Patents

One of Takuma's latest patents is a method for the production of a glycosylated immunoglobulin. This innovative method involves several key steps: first, providing a eukaryotic cell that contains a nucleic acid encoding the immunoglobulin. Next, the eukaryotic cell is cultivated in a medium where the glucose available is kept constant and limited to less than 80% of the maximum amount that the cells can utilize per time unit. Finally, the immunoglobulin is recovered from the culture. This method represents a significant advancement in the efficient production of immunoglobulins.

Career Highlights

Throughout his career, Shinya Takuma has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in immunology.

Collaborations

Takuma has collaborated with esteemed colleagues, including Chikashi Hirashima and Reinhard Franze. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of biotechnology.

Conclusion

Shinya Takuma's contributions to the production of glycosylated immunoglobulins highlight his role as a leading inventor in biotechnology. His innovative methods and collaborations continue to influence the industry and pave the way for future advancements.